NCCN Guidelines List Ropeginterferon Alfa-2b as Preferred Treatment in Polycythemia Vera

Press/Media

Period	24 May 2023

Media coverage

Title	NCCN Guidelines List Ropeginterferon Alfa-2b as Preferred Treatment in Polycythemia Vera
Media name/outlet	OncLive
Country/Territory	United States
Date	24/05/23
URL	ct.moreover.com/?a=50863809608&p=1gw&v=1&x=krshZjWfvZeU9Mt25MRKFA
Persons	John Mascarenhas